New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

Xbira (Abiraterone Acetate tablets)

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call at 9891296838 or Email to discuss.

  • Brand Name- Xbira
  • Innovator Brand Name- Zytiga
  • API-  Abiraterone Acetate
  • Packaging- 120 Tablets
  • Strength- 250 mg
  • Manufacturer Name- Cipla

South Delhi Pharma can facilitate the supply of “Xbira (Abiraterone Acetate)” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Xbira (Abiraterone Acetate) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.


Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:

Query Form


What Xbira is?

Abiraterone  is a CYP17 inhibitor indicated for use:

  • With the combination of corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) as well as metastatic high-risk castration sensitive prostate cancer (mCSPC)
  • May be effective in the prevention of testosterone flare at the initiation of Gonadotropin-Releasing Hormone Agonist (GnRH ) therapy in males with prostate cancer.

What Abiraterone Acetate is?

Abiraterone acetate, sold under the brand name Zytiga among others, is a medication used to treat prostate cancer.[9] Specifically it is used together with a corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC). It should either be used following removal of the testicles or along with a gonadotropin-releasing hormone (GnRH) analog.

Related Products